Literature DB >> 35286704

The Immunogenetics of Melanoma.

Farzaneh Darbeheshti1,2.   

Abstract

Melanoma is a relatively common and deadly type of skin cancer that originates from melanocytes. Cutaneous malignant melanoma results from the interplay between genetic susceptibility and environmental factors. Though the majority of melanoma cases are sporadic, several high and low penetrance mutations have been identified as underlying factors of heritable melanoma. Genetic variations in immune system components are among the most studied factors in melanoma heritability. They are involved in several aspects of the pathogenesis of the tumor including predisposition, cell proliferation, and apoptosis as well as immunotherapy. In this chapter, the hitherto available immunogenetic-related reports on melanoma predisposition and progression are summed up.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Genetic susceptibility; Immunogenetics; Melanoma; Pathogenesis

Mesh:

Year:  2022        PMID: 35286704     DOI: 10.1007/978-3-030-92616-8_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  61 in total

1.  Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-alpha from mast cells. Involvement of mast cells and Langerhans cells in susceptibility to ultraviolet B.

Authors:  P Alard; H Niizeki; L Hanninen; J W Streilein
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease.

Authors:  Rebeca Alonso; Ana Suarez; Patricia Castro; Angel J Lacave; Carmen Gutierrez
Journal:  Melanoma Res       Date:  2005-02       Impact factor: 3.599

Review 3.  The determinants of tumour immunogenicity.

Authors:  Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2012-03-01       Impact factor: 60.716

4.  Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.

Authors:  Rafael Carretero; Ena Wang; Ana I Rodriguez; Jennifer Reinboth; Maria L Ascierto; Alyson M Engle; Hui Liu; Francisco M Camacho; Francesco M Marincola; Federico Garrido; Teresa Cabrera
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

5.  HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.

Authors:  A C Bateman; S J Turner; J M Theaker; W M Howell
Journal:  Tissue Antigens       Date:  1998-07

6.  The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin.

Authors:  Scott N Byrne; Kirsten J L Hammond; Carling Y-Y Chan; Linda J Rogers; Clare Beaugie; Sabita Rana; Felix Marsh-Wakefield; Joshua M Thurman; Gary M Halliday
Journal:  Photochem Photobiol Sci       Date:  2015-04       Impact factor: 3.982

7.  Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice.

Authors:  Lisa Biggs; Chunping Yu; Boris Fedoric; Angel F Lopez; Stephen J Galli; Michele A Grimbaldeston
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

8.  Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Authors:  Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera
Journal:  Immunogenetics       Date:  2008-06-11       Impact factor: 2.846

9.  In vitro mechanism(s) of ultraviolet-induced tumor necrosis factor-alpha release in a human keratinocyte cell line.

Authors:  E Corsini; A Bruccoleri; M Marinovich; C L Galli
Journal:  Photodermatol Photoimmunol Photomed       Date:  1995-06       Impact factor: 3.135

10.  Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Authors:  Marna G Bouwhuis; Andreas Gast; Adina Figl; Alexander M M Eggermont; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.